TDC
PGNX

Thompson Davis & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Thompson Davis & Co’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,000
Closed -$26K – 1314
2014
Q3 		$26K Hold
5,000
– – 0.03% 407
2014
Q2 		$22K Hold
5,000
– – 0.03% 379
2014
Q1 		$21K Buy
+5,000
New +$21K 0.03% 377